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Abstract
Early goal-directed therapy (EGDT) in severe sepsis and septic shock has shown to provide
substantial benefits in patient outcomes. However, these preventive therapeutic interven-
tions are contingent upon an early detection or suspicion of the underlying septic etiology.
Detection of sepsis in the early stages can be difficult, as the initial pathogenesis can occur
while the patient is still displaying normal vital signs. This study focuses on developing
an early warning system (EWS) to provide clinicians with a forewarning of an impending
hypotensive crisis-thus allowing for EGDT intervention. Research was completed in three
main stages: (1) generating an annotated septic shock dataset, (2) constructing multivari-
ate logistic regression EWS models using the annotated dataset, and (3) testing the EWS
models in a forward, causal manner on a random cohort of patients to simulate performance
in a real-life ICU setting.
The annotated septic shock dataset was created using the Multi-parameter Intelligent
Monitoring for Intensive Care II (MIMIC II) database. Automated pre-annotations were
generated using search criteria designed to identify two patient types: (1) sepsis patients
who do not progress to septic shock, and (2) sepsis patient who progress to septic shock.
Currently, manual review by expert clinicians to verify the pre-annotations has not been
completed.
Six separate EWS models were constructed using the annotated septic shock dataset.
The multivariate logistic regression EWS models were trained to differentiate between 107
high-risk sepsis patients of whom 39 experienced a hypotensive crisis and 68 who remained
stable. The models were tested using 7-fold cross validation; the mean area under the
receiver operating characteristic (ROC) curve for the best model was 0.940 ± 0.038.
The EWS models were then tested in a forward, casual manner on a random cohort
of 500 ICU patients to mimic the patients' stay in the unit. The model with the highest
performance achieved a sensitivity of 0.85 and a positive predictive value (PPV) of 0.70.
Of the 35 episodes of hypotension despite fluid resuscitation present in the random patient
dataset, the model provided early warnings for 29 episodes with a mean early warning time
of 582 ± 355 minutes.
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Title: Distinguished Professor in Health Sciences and Technology
Professor of Electrical Engineering
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Chapter 1
Introduction
1.1 Motivation
Early goal-directed therapy (EGDT) for severe sepsis and septic shock has been shown to
provide substantial benefits in patient outcome [1]. A retrospective meta-study found a
significant decrease in sepsis related mortality rates in 10 out of 12 tertiary care hospitals
after the implementation of EGDT protocols; mean mortality rate decreased from 44.8
± 7.8% to 24.5 ± 5.5% [1]. Furthermore, a study conducted by Kumar et al. found a
survival rate of 80% when effective antibiotic therapy was initiated within the first hour
of hypotension [2]. Yet sepsis remains the leading cause of death in noncoronary intensive
care units (ICUs) with associated mortality rates upwards of 50%.
The therapeutic benefits conferred through EGDT are solely contingent upon the early
detection or suspicion of the underlying septic etiology. The difficulty of such a task
is highlighted by the disparity between EDGT results and national epidemiological find-
ings. Morality rates for sepsis remain high not because of the lack of effective therapeutic
interventions-but rather the delay of their administration.
Currently, the majority of research on the early detection of sepsis focuses on the search
for predictive biomarkers. The clinical utility of such a marker, assuming one is found, is
still questionable. In order to request a measurement, the clinician would have to suspect
an underlying septic etiology-which is often overlooked until the patient becomes grossly
symptomatic. Furthermore, lab results may take several hours to return-potentially past
the window of preventive therapeutic intervention.
Ideally, a predictive measure could provide an early warning using either: (1) an instan-
taneously sampled variable, or (2) commonly measured variables. Such a measure could
be continuously monitored independent of the clinician's prior suspicions. Furthermore,
there would be no delay from the measurement of the variable(s) to the issuance of an early
warning.
The focus of this thesis is the development of a septic shock early warning system (EWS)
which uses commonly measured clinical variables. The EWS takes form as a multivariate
logistic regression model designed to predict the hallmark of septic shock: hypotension
despite fluid resuscitation. Ultimately, a reliable early warning would allow clinicians to
administer EGDT protocols while still effective-thus, reducing patient mortality rate.
1.2 Thesis Outline
A brief outline of the thesis is provided below:
* Chapter 2: Background. This chapter presents an overview of sepsis and its associ-
ated disorders to provide context for the current research.
* Chapter 3: Generating an Annotated Septic Shock Dataset. This chapter details the
semi-automated process used to generate the septic shock dataset. The dataset was
subsequently used to build the EWS.
* Chapter 4: Constructing the Septic Shock Early Warning System. This chapter
describes the construction of multivariate regression models used as EWS models.
Results on classifier performance in a static evaluation setting are provided in this
chapter.
* Chapter 5: Evaluating the Septic Shock Early Warning System. This chapter details
the evaluation of the EWS models in a forward, causal manner to simulate performance
in an ICU setting.
* Chapter 6: Discussion & Conclusion. This chapter analyzes the strengths and
weaknesses of the EWS system in the context of overall performance and clinical
applicability. Areas of focus for future work are also discussed.
Chapter 2
Background
This section aims at presenting the reader with an overview of sepsis and its associated
disorders. The chapter does not attempt to be a comprehensive guide but rather a summary
to provide context for the current research. The chapter starts with providing the reader
with the clinical definition of sepsis; epidemiological findings are then presented; two theories
on the pathogenesis of sepsis are offered; the challenges in finding early warning signs are
stated; finally, the chapter concludes with a brief discussion on the usage of machine learning
algorithms in a clinical setting.
2.1 Defining Sepsis
Sepsis is the leading cause of death in noncoronary intensive care units (ICU) in the United
States [3]. Despite its high morbidity rate, sepsis remains an ill-defined disorder. The
sequelae of nonspecific signs and symptoms associated with sepsis make creating a well
defined definition a difficult task. Unfortunately, no biomarkers have yet to come to its
rescue as CPK-MB and troponin have for myocardial infarctions. Definitions based on the
myriad of sepsis symptoms are often criticized with either being overly sensitive with an
associated loss in specificity, or exceedingly involved with little clinical usefulness [4].
Nonetheless, current definitions of sepsis provide an adequate framework to construct
the foundation for research and clinical therapeutics. The core of the current definition
of sepsis arose from the 1991 American College of Chest Physicians / Society of Critical
Care Medicine (ACCP / SCCM) Consensus Conference. This definition was revisited and
slightly modified by the 2001 Internal Sepsis Definition Conference. Both definitions are
detailed below.
2.1.1 1991 ACCP / SCCM Consensus Conference
The 1991 ACCP / SCCM Consensus Conference aimed at providing a set of uniform def-
initions which could be applied to patients with sepsis and its associated complications
[3]. A rising incidence of the disorder coupled with increasing clinical trials for sepsis treat-
ment, created an environment in which infectious related terminology was used with varying
definitions-further complicating management of the disorder. The outcome of the confer-
ence, detailed below, provides a set of definitions used to characterize the progression of the
disorder.
Sepsis refers to a clinical spectrum of complications starting with the initial infection
and ultimately progressing to septic shock as shown in Figure 2-1. The infection can arise
from a variety of agents including Gram-negative bacteria, Gram-positive bacteria, fungi, or
viruses. Sepsis may also occur without a detectable infectious source, in which case microbial
endotoxins are considered the initiators of the clinical progression [5]. Regardless of the
underlying infectious agent, the resultant generalized hyper-inflammatory state triggers
the cascade of events ultimately responsible for progressing the patient through the sepsis
spectrum.
The initial insult manifests as the nonspecific systemic inflammatory response syndrome
(SIRS). SIRS is diagnosed when a patient has two or more of the clinical abnormalities
provided in Table 2.1. The SIRS criteria has been criticized for its oversensitivity and
associated loss of definition specificity [4]. Although it is important to note, Bone et al.
acknowledged a wide variety of noninfectious insults could produce SIRS, and had hopes
future definitions may include aspects of the underlying pathogenesis specific to the disorder
[3].
SIRS Abnormalities
Temperature > 38 0 C or < 36 'C
Heart rate > 90 beats per minute
Repiratory rate > 20 breathes per minute
White blood cell count > 12,000 cells per mm3
or < 4,000 cells per mm3
Table 2.1: According to the 1991 ACCP / SCCM definition, the diagnoses of the systemic inflam-
matory response syndrome (SIRS) is made when patients present with at least two of the clinical
findings above.
}
}
}
}
Figure 2-1: The clinical spectrum of sepsis begins with the initial toxic insult and progresses through
increasing inflammatory response stages. The spectrum ultimately ends in septic shock and/or
multiple organ dysfunction syndrome (MODS).
Two or more of the following conditions:
* Temperature > 380C or <360 C
* Heart rate > 90 beats per min
* Respiratory rate > 20 breaths per min
* White blood count > 12,000 / mm 3
or < 4,000 / mm3
Systemic response to infection:
* SIRS
* Documented or highly suspected
Infection
Sepsis associated abnormalities:
* Sepsis
* Evidence of organ dysfunction,
hypoperfusion, or hypotension
Sepsis induced hypotension:
* Systolic BP < 90 mmHg despite
adequate fluid resuscitation
* Evidence of organ dysfunction,
hypoperfusion, or hypotension
Sepsis
Se
Se si
The diagnosis of sepsis is made when the systemic response can be traced to a doc-
umented (or highly suspected) source of infection. Once again, the patient must present
with at least two of the following SIRS abnormalities: (1) temperature, (2) heart rate, (3)
respiratory rate, (4) or white blood cell count.
Severe sepsis ensues when sepsis is further complicated with organ dysfunction or hy-
poperfusion abnormalities. Evidence of organ dysfunction or hypoperfusion can include,
but is not limited to, lactic acidosis, oliguria, or an acute change in mental status [3].
Septic shock, a subset of severe sepsis, is characterized by sepsis-induced arterial hy-
potension despite adequate fluid resuscitation. Sepsis-induced hypotension is defined as a
sustained systolic blood pressure of less than 90 mmHg or a 40 mmHg drop from base-
line. The hypotension must be persistent and must not be secondary to other causes (i.e.
cardiogenic shock). Evidence of organ dysfunction or hypoperfusion must also be present.
The clause "despite adequate fluid resuscitation" adds further ambiguity to the clin-
ical definition of septic shock. Especially in conjunction with the usage of vasopressors
or inotropic agents, the amount of fluid input deemed as "adequate" can vary substan-
tially. Nonetheless, in order to establish a precise clinical case definition, "adequate fluid
resuscitation" is typically defined as a 20-30 cc/kg volume challenge [1].
2.1.2 2001 International Sepsis Definition
Ten years after the 1991 ACCP / SCCM Consensus Conference was held to establish to
uniform definitions for sepsis and the associated spectrum of progressive injurious processes,
the 2001 International Sepsis Definitions Conference revisited these definitions to evaluate
their efficacy and suggest improvements [6].
Participants of the 2001 Conference agreed the 1991 SIRS definition was overly sensitive
and provided little clinical utility in the initial diagnosis of sepsis. Clinicians did not make
the diagnosis of sepsis based on the 1991 SIRS criteria, but rather by analyzing the host
of symptoms and deciding the patient "looks septic"--regardless of a documented source
of infection [6]. Thus in hopes to increase utility in making the sepsis diagnosis, a more
comprehensive list of SIRS criteria was established as provided in Table 2.2.
Apart from expanding the SIRS list, the conference found no evidence to support any
need for changes in the 1991 definition.
The Conference also proposed a staging system in hopes to be able to stratify patients
Infection, documented or suspected, in addition to some of the following:
General variables
Fever (temperature > 38.3°C)
Hypothermia (temperature < 36 °C)
Heart rate > 90 bpm or > 2 SD above the normal value for age
Tachypnea
Altered mental status
Significant edema or positive fluid balance (>20 cc/kg over 24 hrs)
Hyperglycemia (plasma glucose >120 mg/dL or 7.7 mmol/L)
in the absence of diabetes
Inflammatory variables
Leukocytosis (WBC count > 12,000 cells/mm3 )
Leukopenia (WBC count < 4000 cells/mm3 )
Normal WBC count with > 10% immature forms
Plasma C-reactive protein > 2 SD above the normal value
Plasma procalcitonin > 2 SD above the normal value
Hemodynamic variables
Arterial hypotension (SBP < 90 mmHg,
or an SBP decrease > 40 mmHg from
SVo2 > 70%
Cardiac index > 3.5 L - min - 1 • m - 2
MAP < 70
baseline)
Organ dysfunction variables
Arterial hypoxemia (Pao2 /FIo 2 > 300)
Acute oliguria (urine output < 0.5 mL • kg- 1
or 45 mmol/L for at least 2 hrs)
Creatinine increase > 0.5 mg/dL
Coagulation abnormalities (INR > 1.5 or aP1
Ileus (absent bowel sounds)
Thrombocytopenia (platelet count < 100,000
Hyperbilirubinemia (plasma total bilirubin >
hr-1
FT > 60 secs)
per mm3)
4 mg/dL or 70 mmol/L)
Tissue perfusion variables
Hyperlactatemia (> 1 mmol/L)
Decreased capillary refill or mottling
Table 2.2: 2001 Updated SIRS Definition. WBC, white blood count; SBP, systolic blood pressure;
MAP; mean arterial blood pressure; So,, mixed venous oxygen saturation; INR, international
normalized ratio; aPTT, activated partial thromboplastin time. Adapted from Levy et al [6].
based on their baseline risk and potential to respond to therapy. The proposed PIRO
system stratifies patients based on their Predisposing conditions, the nature and extent of
the Insult (Infection in the case of sepsis), the nature and magnitude of the host Response,
and the degree of concomitant Organ dysfunction. The proposed system requires extensive
testing and refinement before it can be applied in clinical practice.
The Conference suggested future work on defining the clinical spectrum of sepsis disor-
ders should focus on identified biomarkers to confer both increased sensitivity and specificity
to the current definitions [6]. Biomarkers currently being investigated in their role as me-
diators of the sepsis cascade include: interleukin (IL)-6, tumor necrosis factor (TNF)-a,
adrenomedullin, soluble (s)CD14, sELAM-1, MIP-la, extracelluar phospholipase A2, and
C-reactive protein [7, 8, 9, 10, 11].
2.2 Epidemiology
Epidemiological findings of sepsis are marked with high variability because of the inher-
ent imprecision in the current definition of sepsis. The results are highly sensitive to the
case definition for sepsis used in the study. Additionally, retrospective studies (i.e. us-
ing discharge summaries) are at the mercy of clinicians to make diagnoses in a consistent
manner-a difficult feat when most diagnoses are made on the basis of a gut feeling that
the patient is "looking septic".
2.2.1 Incidence
A 1990 study conducted by the Center for Disease Control (CDC) found that the incidence
of septicemia had increased from 73.6 per 100,000 patients in 1979 to 175.9 per 100,000
in 1989 [12]. The increased incidence was attributed to the following four reasons: (1)
increased prevalence of HIV/AIDS, (2) prolonged survival and increased duration of risk
for HIV/AIDS patients, (3) increased usage of invasive monitoring devices (i.e. intravenous
catheters), and (4) increased ability to diagnose the disorder [13]. It is important to note
that the applicability of these results to sepsis is limited by the case definition used by the
study (septicemia versus the 1991 definitions of sepsis).
A prospective observational study completed in 1995 by Rangel-Frausto et al. inves-
tigated the incidence of sepsis in the ICUs and general medical wards in a tertiary care
medical teaching center [14]. The study examined 3,708 admitted patients using the 1991
ACCP / SCCM consensus criteria. 68% of patients fulfilled the SIRS criteria; of this subset
of patients, 26% went on to develop sepsis, 18% developed severe sepsis, and 4% developed
septic shock.
Sands et al. examined the occurrence rates of sepsis in eight academic medical centers
from 1993 to 1994 [15]. The study used a modified, more stringent, version of the 1991
ACCP / SCCM consensus criteria. An assessment of 12,759 ICU and non-ICU patients
yielded an occurrence rate of 2.0 cases per 100 admissions; it is important to note, there
was substantial variability amongst the medical centers.
Whether arising from fundamental differences in patient populations or case definitions
used by investigators, there is a high degree of variability in findings of the studies men-
tioned above. Similar to the studies presented, most of the data used in epidemiological
studies of sepsis is derived from tertiary care centers. Thus, the results cannot be general-
ized to primary or secondary care hospitals without knowing the size, demographics, and
pathologies of the populations served by these hospitals [13].
2.2.2 Mortality
Morality rates observed for sepsis varied substantially amongst studies examining the out-
come of patients with sepsis. The 1990 CDC study observed a decrease in mortality rate
in patients with septicemia from 1979 to 1989 (31.0% and 25.3% respectively). The de-
creased mortality rate was attributed to a combination of changes in the demographics of
the affected population and improvements in the treatment of the disorder.
A meta-analysis of 131 studies from 1958 to 1997 (99 prospective and 32 retrospective)
conducted by Friedman et al. found an overall mortality rate of 49.7% [16]. A wide range
of morality rates was found amongst the studies, with the majority reporting rates between
40-80%. The meta-analysis reported an overall decrease in mortality rate over the years;
however, the authors warned this result should be approached with caution because of the
heterogeneity of both: (1) the patient populations, and (2) sepsis case definitions between
studies.
Despite the high variability in mortality rates, one trend was consistently seen amongst
studies-an increase in mortality risk with the stepwise progression of severity. A prospec-
tive study of patients admitted in 99 Italian ICUs found a 36% mortality rate in patients
with sepsis, 52% in patients with severe sepsis, and 82% in patient with septic shock [17].
Rangel-Frausto et al. observed a similar increase in mortality rate in the 3,708 patients
studied (7% from SIRS, 16% from sepsis, 20% from severe sepsis, and 46% from septic
shock).
2.3 Pathophysiology
The traditional theory on sepsis views the disorder as an uncontrolled inflammatory re-
sponse resulting in immune-mediated injury. The progression of the disorder is not a direct
consequence of the initial insult, but rather the maladaptive release of inflammatory cy-
tokines. However, recent research has challenged this view and points towards an immune
suppressed state rather than an overzealous immune response. Overviews of both theories
are provided below.
2.3.1 Immune Mediated Injury
The initial immune reaction to infection involves a series of complex, interdependent cellular
and non-cellular processes. Normally, these processes work to heighten the body's immune
response and help clear the underlying infection. However, when this immunologic cascade
functions in an unregulated manner, the body's defense mechanism can cause extensive
immune-mediated bystander tissue injury-ultimately resulting in organ dysfunction. This
uncontrolled triggering of the body's defense mechanisms by the invading infectious agent
is the underlying pathway of injury in sepsis.
The immune response to infection includes aspects of both innate and adaptive im-
munity. This response includes the release of cytokines, the activation of neutrophils,
monocytes, and microvascular endothelial cells, in addition to the activation of neuroen-
docrine reflexes and plasma protein cascade systems (i.e. complement system), the intrinsic
and extrinsic pathways of coagulation, and the fibrinolytic system [18]. The extensive
over-activation and complex interactions between these immunologic processes result in
microvascular injury and tissue ischemia characteristic of septic shock [19].
Cellular Mediators
Macrophage. Macrophages play a pivotal role in orchestrating the initial immune re-
sponse to infection. Macrophages, as a result of their phagocytic activity, are the primary
immune cells to interact with the invading pathogen. Through the release of various cy-
tokines, macrophages are able to modulate a wide range of inflammatory responses. How-
ever, the unregulated macrophagic response seen in sepsis, in conjunction with other active
immune cells, can result in an uncontrolled destructive cytokine cascade [20]. The secretion
of these proinflammatory cytokines (TNF-a, interferon-'y, IL-1, IL-2, and IL-6) synergisti-
cally act to amplify the immune response [18, 21].
Neutrophils. Neutrophils are the key immune players in the eradication of pathogens.
Neutrophils generate a variety of biochemical agents targeted to clear the invading pathogen.
These agents include proteases, cytokines, and toxic oxygen radicals [18]. Similar to
the macrophage response, unregulated stimulation of neutrophils can result in significant
immune-mediated injury as summarized in Table 2.3. Furthermore, the proinflammatory
state can result in the aggregation of neutrophils in the microcirculation resulting in occlu-
sion of the microvasculature-and ultimately tissue ischemia [18].
Endothelium. Endothelial cell injury leads to the hallmark decreased systemic vascular
resistance (SVR) and hypotension observed in septic shock. Injurious endothelial processes
are mediated by the production of a variety of noxious substances (including oxygen free
radicals, arachidonic acid metabolites, products of anaerobic metabolism and lactic aci-
dosis), complement activation, platelet aggregation, neutrophil activation, and monocyte
production of cytokines [18]. Additionally, endothelial cells may themselves transform into
a proinflammatory state causing increased microvascular permeability with subsequent fluid
loss into the interstitium [19]. Vasodilation is the direct result of the release of various va-
soactive molecules during the inflammatory cascade mentioned above [19]. The vasodilation
combined with fluid loss produce the persistent hypotension observed in septic shock pa-
tients.
Mediator Origin Affects
TNF-a Macrophage Production of elastase, superoxide ion, hydrogen perox-
ide, sPLA2, PAF, leukotriene B4, and thromboxane A2
IL-1 Macrophage Production of prostaglandins, elastases, collagenases
Promotes transendothelial migration of neutrophils
Activates endothelial microvascular cells
ROS Leukocytes Disrupt cell membrane and lead to necrosis and/or apop-
tosis
NO Endothelium Vasodilation
Protein and membrance phospholipid alterations
Mitochondial dysfunction
ILM Phospholipid Production of PAF, and AA
metabolism
AA Various Production of prostaglandins and luekotrienes
Conversion to isoprostanes by free radical peroxidation
PAF Various Stimulation of neutrophil adhension to endothelium
Increase microvascular permability
Table 2.3: Inflammatory Mediators of Sepsis. TNF, tumor necrosis factor; sPLA2, secretory phos-
pholipase A2; IL, interleukin; ROS, reactive oxygen species; NO, nitric oxide; ILM, inflammatory
lipid mediators; AA, arachidonic acid; PAF, platelet-activating factor.
Myocardial Dysfunction
Myocardial dysfunction, as evidenced by biventricular dilatation and reduced ejection frac-
tion, is commonly observed in patients with severe sepsis and septic shock. Depressed
cardiac function is a result of circulating myocardial depressant factors (TNF-alpha and
IL-lbeta) and not myocardial hypoperfusion. Both nitric oxide (NO)-dependent and NO-
independent mechanisms are responsible for the reduced cardiac contractility [22].
2.3.2 Reviewing the Traditional View
Results from recent work have challenged the notion that injury from sepsis is an immune
mediated process. In fact, patients with sepsis have a loss of delayed hypersensitivity, an
inability to clear infection, and a predisposition to nosocomial infections-a state more
consistent with immunosuppression rather than unregulated immunological function [21].
CD4 T cells have the ability to secrete two different cytokine profiles: (1) a proin-
flammatory profile, Thl or (2) an anti-inflammatory profile, Th2. Although there is a
proinflammatory response at the site of infection, there is a systemic shift to an anti-
inflammatory response outside the infected area [23]. Histological findings from spleens of
deceased sepsis patients show a decreased count in the number of B cells, CD4 T cells, and
follicular dendritic cells [21]. In contrast to the immune mediated view, a prospective study
on 35 postoperative patients with sepsis showed survival was correlated with recovery of
the inflammatory (IL-12 p40, and IL-lbeta) rather than anti-inflammatory response (IL-10)
[24].
2.4 Early Warnings of Sepsis
Early goal directed therapy has proven effective in reducing mortality risk for patients
diagnosed with septic shock [1]. However, currently no early warning signs or biomarkers
have been found to predict the transition from severe sepsis to septic shock in the adult
population. In neonates, detecting reduced variability and transient decelerations in heart
rate have proved effective in the early diagnosis sepsis [25, 26]. Unfortunately, this trend
does not carry over to the adult population.
Various biomarkers have been investigated as predictors for patient outcome (including
TNF-a, various ILs, interferon-y, and lactate). Although some markers provide reasonable
efficacy in predicting outcome, none are able to provide early warning. It is possible that the
underlying pathologic processes responsible for the transition to septic shock have already
been set in motion when levels of these biomarkers become clinically abnormal.
2.5 Use of Machine Learning Algorithms
Machine learning algorithms have been used in clinical settings for several decades. Computer-
based clinical-assist tools have been developed to perform a variety of tasks ranging from
predicting drug response to carcinoma classification. Machine learning algorithms are ideal
when data is plentiful but theory is lacking-an accurate description of many of the clinical
challenges faced today.
Computer-based clinical-assist tools gained notoriety in the early 1970's with the devel-
opment of MYCIN. Although not technically a machine learning algorithm, MYCIN was
a rule-based expert system designed to recommend a course of antimicrobial therapy [27].
MYCIN outperformed five Stanford Medical School faculty members; however, the system
was never used in practice because of ethical and legal complications [27].
In the 1990's, the Acute Physiology and Chronic Health Evaluation (APACHE) II system
gained popularity as a measure of the severity of disease for ICU patients. APACHE uses a
multivariate regression model (feature matrix including 12 physiologic measurements, age,
and previous health status) to prognostically stratify patients [28]. The APACHE score is
generated during the initial 24 hours of a patient's stay. Due to therapeutic interventions,
there is little utility of a recomputed APACHE score after the initial 24 hours. Currently,
the Simplified Acute Physiology Score (SAPS) II is more commonly used as the method
does not require regression calculations [29].
Machine learning algorithms designed for medical usage are typically run on static
datasets (e.g. gene arrays, initial physiologic values, etc.) to perform static classifica-
tion and/or stratification. A search on PubMed found no clinical algorithms designed to
run in real-time on time variant data. Ultimately, it is the focus of this research to develop
such a system to act as an early warning system for septic shock.
Chapter 3
Generating an Annotated Septic
Shock Dataset
Development of an early warning system for septic shock requires an annotated dataset. As
with any machine learning exercise, the predictive value of the classifier is highly dependent
upon the accuracy and fidelity of the initial training dataset. Currently, there are no publicly
available annotated datasets for septic shock. Thus, to support the current research, a
dataset with the following properties was generated:
* Set of positive septic shock patients:
- Documented time of transition from sepsis or severe sepsis to septic shock
- Hypotension not secondary to any other causes (i.e. cardiogenic shock)
- Sufficient data to support analysis
* Set of negative control patients:
- Set of high risk sepsis patients who do not transition to septic shock
- Sufficient data to support analysis
This chapter details the process of generating an annotated septic shock dataset that
fulfills the criteria listed above.
3.1 MIMIC II Database
The Multi-parameter Intelligent Monitoring for Intensive Care II (MIMIC II) database is
the product of an interdisciplinary team from academia (MIT), industry (Phillips Medi-
cal Systems), and clinical medicine (Beth Israel Deaconess Medical Center); the extensive
temporal database was created to facilitate the development and evaluation of ICU decision-
support systems [30]. In its current state, the MIMIC II database houses approximately
17,000 patient records collected from various Intensive Care Units (ICUs) of the Beth Is-
rael Deaconess Medical Center. All patient data used in this study were derived from the
MIMIC II database.
3.1.1 Input Data
This section describes the clinical data used for analysis. Specifics on how the data were
used is provided in more detail in the discussion of each algorithm.
Four distinct types of clinical information were extracted for each patient: (1) physiologic
values, (2) lab values, (3) medications, and (4) fluid administration. All values are nurse
verified; a nurse enters or confirms a value (for the measurement of interest) which is
representative of the patient's current state. Because of this validation, sampling rates for
physiologic values, medications, and fluids vary from 15-120 minutes, with a mean and
median of approximately 60 minutes. Sampling rates for lab values depend upon how often
the measurements are requested by the clinician.
Continuously sampled data in the ICU are prone to artifact and noise corruption. The
choice to use nurse verified data was made in order to avoid the challenges of identifying
artifactual versus physiologic abnormalities. The resultant loss in sampling frequency should
not affect early warning capabilities as the devolution towards septic shock is a process which
may takes hours to days.
Physiologic values. A range of physiologic variables (hemodynamic, respiratory, metabolic)
was extracted for each patient. The list of variables is provided in Table 3.1. Not all patients
had readings for all variables listed, nor were all variables used to determine if the patient
experienced septic shock. Variables required to determine the onset of shock are referenced
in Section 3.2.1. Variables used to develop the early warning system are detailed in Section
4.1.1.
Estimated cardiac output was calculated using the Liljestrand technique [31]; estimated
total peripheral resistance was calculated using estimated cardiac output. Although the esti-
mates were calculated using nurse verified data, there was significant noise in the estimates-
resulting in marginal utility.
Physiologic Data
Systolic BP Mean BP Diastolic BP
Pulse Pressure CVP Cardiac Output
Heart Rate Temperature Respiratory Rate
Arterial pH Spo2
Lactate
WBC
Creatinine
CPK
Troponin
Table 3.1: Clinical variables extracted for each patient. BP, blood pressure; CVP, central venous
pressure; Spo2, pulse oximetry oxygen saturation; WBC, white blood cell count; CPK, creatine
phosphokinase
Medications. All medications administered throughout the course of the patient's stay
were extracted from the MIMIC II database. Medication information was not used in
generating the annotated dataset, but vasopressor/inotrope administration was used in
establishing the gold standard for the early warning system (documented in Section 5.2.1).
Fluid administration. All fluids administered throughout the course of the patient's
stay were extracted from the MIMIC II database. Fluid information was used to determine
if a patient's hypotension persisted despite fluid resuscitation.
3.1.2 Challenges of Manual Annotation
Annotations are currently completed on a case-by-case manner in which expert clinicians
manually examine each case and annotate significant clinical findings. Such findings include
diseases (adult respiratory distress syndrome, septic shock, hypovolemia, etc.), symptoms
(chest pain, diarrhea, etc.), significant medication changes, vital sign changes (tachycardia,
hypotension, etc.), waveform abnormalities (arrhythmias), and abnormal laboratory values
(CK, ALT, etc.) [32]. Currently annotators have little guidance and must wade through
discharge summaries, nursing notes, waveform data, and physiological data to review each
case [33]. Consequently, it may take annotators anywhere from 30 minutes to several hours
to review a single case.
Generating an annotated dataset for septic shock through the manual review of the
17,000 cases in the MIMIC II database is not feasible. A more plausible option would
be to generate a pre-annotated dataset which would guide annotators to specific problems
in a particular region of interest-greatly reducing the time required to annotate a single
case. Accordingly, a preannotated dataset was generated from the MIMIC II database;
methodology is provided in the following sections.
Lab Values
3.2 Automated Pre-Annotation
3.2.1 Pre-Annotation Process
The automated pre-annotation process is a method to identify and pre-annotate septic shock
patients from the 17,000 patient MIMIC II database. A schematic of the overall process
is shown in Figure 3-1. Initially, all patients with an ICD-9 coding for septic shock are
selected. Patients with incomplete or missing data are subsequently removed. Patients with
sufficient data for analysis are passed to the septic shock onset detector which generates the
pre-annotation. Finally, the pre-annotations are confirmed or rejected by manual review.
A breakdown of patient numbers and statistics is given in Section 3.2.3.
Figure 3-1: Schematic of the automated pre-annotation process. Initially, all patients with an ICD-9
coding for septic shock are selected. Patients with incomplete or missing data are removed. Patients
with sufficient data for analysis are passed to the septic shock onset detector which generates the
pre-annotation. Finally, the pre-annotations are confirmed or rejected by manual review.
Step 1: ICD-9 Search
The International Classification of Diseases (ICD)-9 was published by the World Health
Organization in 1979. The system provides a method of disease classification which is
commonly used in hospital reimbursement systems. Clinicians will typically code a patient
upon discharge with all disorders he or she experienced while in the unit. The ICD-9 coding
for septic shock is 785.52.
The preliminary ICD-9 search provides a prescreening method to identify septic shock
patients. However, it should be noted that identifying patients solely based on ICD-9
codings suffers from both poor sensitivity and specificity. Approximately only one quarter
of patients identified with septic shock ICD-9 codes actually had septic shock as defined by
the 1991 ACCP / SCCM consensus conference. Furthermore, clinicians can often miss the
diagnosis or fail to code the patient resulting in a loss of sensitivity.
Step 2: Data Filter
A data filter was used to ensure all patients had sufficient data for further analysis. The
filter required the patient to have at least 10 measured values of systolic blood pressure,
heart rate, temperature, and respiratory rate (roughly 10 hours of data); additionally, two
white blood cells counts were required. This minimum data requirement corresponds to
approximately one day of ICU data (assuming a 12-hour white count interval). The list
of required variables was chosen as they are the minimum number necessary to make the
diagnosis of septic shock based on the 1991 ACCP / SCCM definition.
Step 3: Septic Shock Onset Detector
The Septic Shock Onset Detector (SSOD) is the core of the automated pre-annotation
algorithm. The SSOD has two main functions:
1. Classify the patient into one of the following three categories:
a) Non-sepsis
b) Sepsis or severe sepsis without septic shock
c) Septic Shock
2. Identify the onset time or transition time from sepsis / severe sepsis to septic shock.
The SSOD completes the previous tasks in a two-step process: (1) determine if the
patient exhibited the systemic inflammatory response syndrome (SIRS) and (2) if so, does
the patient transition into septic shock. The criteria used for SIRS and septic shock are
those defined by the 1991 ACCP / SCCM Consensus Conference (Section 2.1.1). Since
the patients had ICD-9 codings for septic shock, it was assumed they had a documented or
highly suspected source of infection. The 1991 definition was chosen over the 2001 definition
based on the ease of implementation.
SIRS. The first step of the SSOD is to determine the time intervals over which the patient
exhibited SIRS. SIRS requires abnormalities in at least two of the following four variables:
(1) heart rate, (2) temperature, (3) respiratory rate, and (4) white blood cell count (WBC).
The following implementation choices were made:
* Abnormal values for the individual variables must exceed 5 hours in order to be
considered for the SIRS criteria. For example, if a patient was febrile from hour 1
to hour 3, after which he was afebrile-that interval would not be considered when
determining SIRS abnormalities.
* SIRS intervals that were less than 6 hours apart were merged together to form a single
interval. For example, if the patient experienced tachycardia and hyperventilation
from hours 1 to 14 and then became tachycardic and febrile from hours 18 to 23, the
SIRS interval would be from hours 1 to 23.
* If the first or last measured value for a variable met the SIRS threshold, then the time
of abnormality for that variable was taken to be the start or end of the patient record.
For example, take the case in which a patient was febrile from hours 1 to 23 but had
normal values for heart rate and respiratory rate. The first WBC was taken at hour 6
and was found to exceed the SIRS threshold-then the patient's SIRS interval would
start at hour 1 and not hour 6.
Septic shock onset. The second step of the SSOD is to determine if and when the
transition to septic shock occurs in the subset of patients whom exhibited sepsis or severe
sepsis. The transition or onset of septic shock was defined as sepsis-induced hypotension
which persisted longer than 30 minutes. The identification of sepsis-induced hypotension
was made using the following process:
1. Find all regions of hypotension (systolic blood pressure < 90 mmHg for > 30 minutes)
that occur during a SIRS interval.
2. Calculate fluid input one hour prior to the onset of hypotension to half way through
the region of hypotension'. Iterate for all regions of hypotension.
3. If total fluid input is > 600 mL then classify as sepsis-induced hypotension. If multiple
regions are found that satisfy this criteria, the first is taken as the onset. Otherwise,
the hypotensive region is likely to be responsive to fluid resuscitation and thus not
septic shock.
'Calculating fluid input from one hour prior to halfway through the hypotensive region makes the process
noncausal. However, causality is irrelevant in retrospective annotation. How this method can be used in a
forward, causal manner is outlined in Section 3.2.4
3.2.2 Sample Patient Run
Figures 3-2 and 3-3 show two sample runs of the SSOD on patient data. Heart rate,
temperature, respiratory rate, and WBC are used to find the SIRS interval. Systolic blood
pressure is used to determine hypotension. Regions of abnormalities are plotted in red. The
green vertical line denotes the start of SIRS, whereas the black line denotes the end. The
red vertical line indicates the onset of septic shock as determined by the algorithm. Lactate
levels are shown as a measure of tissue perfusion.
3.2.3 Baseline Patient Characteristics
The MIMIC II database has a total of 17,082 patient records. 459 patients had an ICD-9
coding for septic shock. Only 261 of the 459 patients had sufficient data for analysis. Out
of the 261 patients, 250 exhibited SIRS while in the unit and 65 progressed to septic shock.
Baseline patient characteristics are provided in Table 3.2.
3.2.4 Real-time Usage of the SSOD
In order to use the SSOD in a forward, causal manner, the only modification required is the
method of calculating fluid input. One potential causal method would be to calculate fluid
input one hour prior to the onset of hypotension up to the current time. If the hypotensive
episode lasts for at least half an hour and the patient has received greater than a specified
fluid input (e.g. > 600 mL), then the hypotension can be considered insensitive to fluid
resuscitation. Although this would not provide any early warning, it could raise the concern
for a specific etiology the clinician may have overlooked.
3.3 Manual Review
The final step of creating the annotated septic shock dataset requires manual review of
the automated pre-annotations. The output of the SSOD was interfaced with the current
annotation station to provide reviewers an accessible way to view the pre-annotations and
record their decisions [33]. The output interface provides annotators with the interval of
hypotension, and associated SIRS abnormalities, fluid input, and medications. A screen
shot is provided in Figure 3-4.
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Figure 3-2: Sample run of the SSOD on patient 69869. The patient entered the ICU with an elevated
heart rate, but was neither febrile nor hyperventilating. The first WBC measurement exceeded the
SIRS threshold so the SIRS interval began at the beginning of the patient's stay as denoted by the
green vertical line (black line denotes end). He exhibited SIRS through his stay with abnormalities
in all four SIRS criteria. The patient became hypotensive throughout his stay (red segments in the
ABPSys plot). The patient experienced a 70-minute long hypotensive episode at hour 27 (denoted
by vertical red line). He received approximately 1200 mL of fluid but remained hypotensive while on
pressors. Thus, this is pre-annotated as the onset of septic shock. The patient's condition continues
to worsen, and ultimately he expires on day 6.
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Figure 3-3: Sample run of the SSOD on patient 63668. The patient entered the unit with an
elevated heart rate and respiratory rate. White count remained elevated throughout the patient's
stay. The first SIRS interval starts upon admittance and lasted for approximately one day. The
patient experienced an hour-long hypotensive episode at hour 8 (denoted by the red vertical line);
he received nearly 800 mL of fluids but remained hypotensive while on pressors. Thus, this is pre-
annotated as the onset of septic shock. However, the patient's condition improved as indicated by
the falling lactate levels and rise in blood pressure. The patient experienced another SIRS interval
later in his stay-although this episode is unlikely to have been caused by his initial infection.
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Sepsis/Severe Sepsis
(n = 185)
Admit
Septic Shock
(n = 65)
Admit
65 ± 15 (66)
52 (97)
Physiological Values
SIRS criteria
Systolic BP, mmHg
HR, beats per min
Temperature, OC
RR, breathes per min
WBC, cells/mm3
Miscellaneous
Pulse Pressure, mmHg
Arterial pH
Spo2, %
Total fluids, mL
0-6 hrs
6-24 hrs
0-24 hrs
Vasopressors/Inotropes
0-6 hrs, %
6-24 hrs, %
0-24 hrs, %
115 ± 24 (112)
95 ± 20 (95)
36.6 ± 2.8 (36.9)
20 ± 7 (19)
15.0 ± 10.2 (13.9)
57 ± 20 (54)
7.33 ± 0.11 (7.33)
97 ± 6.5 (99)
2298 + 3618 (1102)
3010 ± 2513 (2366)
5200 ± 5065 (3902)
58 (145)
10 (25)
68 (170)
61 ± 17 (64)
60 (39)
105 ± 22 (102)
106 ± 25 (107)
37.1 + 1.2 (36.9)
22 ± 8 (22)
18.1 ± 14.4 (15.1)
47 + 17 (46)
7.30 + 0.11 (7.31)
94 + 12 (97)
2654 ± 2748 (2155)
5445 ± 4704 (4224)
7971 ± 5856 (6115)
67 (43)
11 (7)
78 (50)
61 ± 17 (64)
60 (39)
81 ± 7 (82)
104 ± 23 (105)
37.4 + 1.2 (37.4)
23 ± 7 (23)
18.7 ± 16.6 (14.6)
32 ± 10 (35)
7.29 + 0.12 (7.28)
92 ± 14 (97)
2671 ± 1964 (2348)
3791 ± 3090 (2672)
6368 ± 4337 (5171)
78 (51)
3 (2)
81 (53)
Table 3.2: Baseline patient characteristics for patients with sepsis/severe sepsis and septic shock.
Onset time as determined by the septic shock onset detector.
SIRS, systemic inflammatory response syndrome; BP, blood pressure; HR, heart rate; RR, respiratory rate; WBC,
white blood cell count; Spo 2, pulse oximetry oxygen saturation. Vasopressor/Inotropes presented as % of patients
started during time interval.
Start time (t = 0) for fluid and medication data is time of admission under admit columns, and onset of septic
shock under onset column.
Continuous values presented as mean ± std (median); dichotomous values presented as % (n).
Age, yrs
Male sex, %
Onset
IN Serc Evluto - aintbO
SEARCH HITS
Search Tp e
Septic Shock (onset)
s Descriptor. Septic Shock (onset)
Time: 2012-05-01 20:44:59
Search Criteria:
Overall hemodynamic disturbance:
SEPTIC: Hypotension despite fluid resuscitation
Interval of hemodynamic disturbance:
2012-05-01 20:44:59 to 2012-05-01 21:59:59
SIRS Abnormalities:
HR >90
RR 20
BC > 12
Fluid 1 hour prior to halfway through interval: 1231 ml
Medications:
Fentanyl
Levophed_k
tivan
Figure 3-4: Screen shot of the manual review interface.
At the current time, only a small fraction of the pre-annotations have been manually
reviewed by clinicians. I have sorted through the pre-annotations to eliminate any obvious
errors, but subtleties were likely to be missed. Consequently, the annotated septic shock
dataset used for generating the early warning system is predominately the dataset of pre-
annotations.
3.4 Final Dataset
The final annotated septic shock dataset comprises of 250 patients. 185 of the 250 patients
exhibited sepsis or severe sepsis while in the ICU. The remaining 65 progressed to septic
shock. Annotations for the septic shock patients include the onset time of shock. Further
manual review is required to ensure the hypotension experienced by the septic shock patients
was not secondary other causes.

Chapter 4
Constructing the Septic Shock
Early Warning System
This chapter details the construction of the septic shock early warning system (EWS). The
EWS is a multivariate logistic regression model designed to differentiate between patients
with sepsis and those who progress to septic shock. Six separate EWS models were con-
structed using the annotated septic shock dataset discussed in Chapter 3. Performance of
the models was evaluated through various discriminatory tests; overall performance amongst
the models was nearly identical. Evaluation of the EWS models in a forward, causal manner
on a random cohort of patients is provided in Chapter 5.
4.1 Training Dataset
The training dataset used to construct the six EWS models was generated from the an-
notated septic shock dataset. The training dataset comprises of two patient types: (1)
sepsis/severe sepsis patients who do not progress to septic shock, and (2) septic shock pa-
tients. The nonshock sepsis patients were used as the negative group to maximize the
model's specificity when run in a forward, causal manner on a random patient population.
Each entry in the training dataset contained the following three pieces of information:
1. The patient's classification (nonshock sepsis or septic shock)
2. Time of interest
3. Feature matrix of physiologic values associated with the time point
4.1.1 Feature Extraction
Reference Time
The time point associated with each patient is used to generate the feature matrix of
physiologic values. The reference time for nonshock sepsis patients is a random time sample
from the middle of the patient's first SIRS interval; the reference time for septic shock
patients is dependent on the classifier. Each classifier is trained using a different reference
time-30, 60, 90, 120, 180, or 240 minutes prior to the onset of shock.
Feature Matrix
The feature matrix for the EWS comprised of the following ten physiologic values: (1)
systolic blood pressure, (2) pulse pressure, (3) heart rate, (4) temperature, (5) respiratory
rate, (6) white blood cell count, (7) arterial pH, (8) SpO2, (9) estimated cardiac output, and
(10) estimated total peripheral resistance. Three previous values from the reference time
were extracted. Additionally, percent changes from consecutive readings were calculated.
Thus, the resultant feature matrix consisted of 50 variables-30 physiologic measurements,
and 20 percent changes.
Physiologic values were normalized to a [0,1] range using the maximum and minimum
values provided in Table 4.1. Values below or above the thresholds were set to 0 or 1,
respectively. This scaling procedure provided a basic data validity check by eliminating
implausible physiologic values.
Variable Normalization Range
Systolic Blood Pressure, mmHg 60 - 180
Heart rate, beats per min 50 - 180
Temperature, OC 34 - 40
Respiratory rate, breaths per min 5 - 50
White blood cell count, cells per mm3  0 - 45
Pulse pressure, mmHg 15 - 80
Cardiac output estimatea 15 - 55
Total peripheral resistancea 1 - 7
Arterial pH 7.05 - 7.55
Spo 2, % 60- 100
aEstimates could not be calibrated to real values and thus remain unitless
Table 4.1: Normalization ranges for the EWS feature matrix. Physiologic values were normalized to
a [0,1] range using the maximum and minimum values provided above. Values below or above the
thresholds were set to 0 or 1 respectively.
Patients who did not have sufficient data to generate a full feature matrix were excluded
from further analysis. For example, if a patient did not have a white blood cell count or
arterial pH measurement prior to the reference time, he or she was eliminated from the
training dataset. As a result of the requirement of a full feature matrix, the annotated
dataset of 250 patients (185 nonshock versus 65 shock) was reduced to approximately 110
patients. The training dataset varied slightly between models because different reference
times were used to build each classifier. The final dataset consisted of approximately 110
patients, with a 60:40 breakdown of nonshock versus shock patients.
4.2 Training the Classifier
The septic shock EWS is a multivariate logistic regression model. When training the clas-
sifier, a greedy forward method was implemented to select the k-best variables from the
feature matrix. During the first iteration, univariate regression models were built for each
variable. The best classifier, as judged by area under the receiver operating characteristic
(ROC) curve, was selected. In subsequent iterations, new variables were added using the
same methodology. The process was stopped when improvement in the area under the ROC
curve (AUC) was less than 2%. Furthermore, variables were excluded with an exit criteria
of p > 0.10.
Six different classifiers were constructed since the reference times for each classifier
varied. Six time points prior to the onset of septic shock were used: 30, 60, 90, 120, 180,
and 240 minutes.
4.3 Results
4.3.1 Cross Validation
The classifiers were initially evaluated using a seven-fold cross validation method. As shown
in Table 4.2, there is a downward trend in mean AUC as the reference time prior to the
onset of shock increases. The single exception is the 120 minute prior classifier which has an
AUC nearly equal to that of the 30 minute prior model. Overall performance discrimination
using differences in AUCs is not possible as there is substantial overlap in the 95% confidence
intervals.
Model AUC Accuracy Sensitivity Specificity
30 Minutes 0.940 ± 0.038 0.864 0.857 0.868
60 Minutes 0.928 ± 0.050 0.872 0.902 0.853
90 Minutes 0.893 + 0.085 0.869 0.821 0.897
120 Minutes 0.936 + 0.053 0.888 0.769 0.956
180 Minutes 0.885 + 0.099 0.858 0.737 0.926
240 Minutes 0.874 + 0.078 0.875 0.861 0.882
Table 4.2: Area under the receiver operating characteristic curve (AUC), accuracy, sensitivity, and
specificity for all EWS models. Accuracy, sensitivity, and specificity given for the threshold that
maximizes accuracy. AUC presented as mean ± std.
4.3.2 Testing & Training on the Whole Dataset
After the initial cross validation evaluation, models for each reference time point were
created using the whole dataset; the models were then tested on the same dataset. Figure
4-1 plots the ROC curves for each of the models. Similar to cross validation evaluation, the
curves are essentially superimposable with no significant difference in the AUCs.
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Figure 4-1: ROC curves for EWS models
Accuracy, sensitivity, and specificity values at the threshold which maximizes accuracy
are provided for each model in Table 4.2. All models performed with accuracies in the mid
to upper 80's. An overall trend of decreasing sensitivity and increasing specificity is seen as
the reference time prior to onset of shock increases.
4.3.3 k-best Variables
The k-best variables selected by each classification model are provided in Table 4.3. The
associated / coefficients, adjusted odds ratios, and p-values are also provided. Odds ratios
are adjusted to set increment increases in the variable of interest. For example, odds ratios
given for systolic blood pressure are for 10 mmHg increases. The complete adjustment
increments are provided in Table 4.4.
Variable Adj OR P Coeff p value
ABPSys 0.44 -9.76 < 0.001
HR 1.70 6.93 0.007
SpO2  0.30 -9.49 0.011
RR 2.01 6.32 0.004
ArtpH 0.45 -3.98 0.041
(a) 30 Min Prior
Variable Adj OR 3 Coeff p value
ABPSys 0.38 -11.64 < 0.001
RR 2.00 6.24 0.002
ArtpH 0.45 -4.00 0.044
(c) 90 Min Prior
Variable Adj OR P Coeff p value
ABPSys
SpO2
ArtpH
WBC
0.60 -6.08
0.13 -16.62
0.26 -6.81
2.27 3.70
(e) 180 Min Prior
0.005
< 0.001
0.001
0.039
Variable Adj OR 0 Coeff p value
ABPSys 0.42 -10.38 < 0.001
HR 1.69 6.84 0.004
RR 2.23 7.20 0.001
WBC 2.55 4.21 0.025
ArtpH 0.50 -3.46 0.059
(b) 60 Min Prior
Variable Adj OR P Coeff p value
ABPSys 0.39 -11.43 < 0.001
RR 2.15 6.88 0.002
SpO2  0.24 -11.55 0.010
ArtpH 0.39 -4.77 0.023
(d) 120 Min Prior
Variable Adj OR P Coeff p value
ABPSys
RR
PP
CO
0.63
2.90
0.55
1.81
-5.60
9.59
-7.80
4.76
0.005
0.001
0.001
0.009
(f) 240 Min Prior
Table 4.3: k-best variables selected
adjusted odds ratios, and p-values.
ABPSys, systolic blood pressure;
respiratory rate; ArtpH, arterial pH;
cardiac output.
by each classification model with the associated 3 coefficients,
HR, heart rate; SpO2, pulse oximetry oxygen saturation; RR,
WBC, white blood cell count; PP, pulse pressure; CO, estimated
All models selected systolic blood pressure as the best indicator for progressing to septic
shock. The two earlier models (30 and 60 minutes) selected HR as the second best indicator
while the later models selected a respiratory indicator (either respiratory rate or SpO2.).
Five out of the six models picked either respiratory rate or arterial pH. White blood cell
count entered into two of the models (60 and 180 minutes). Pulse pressure and the associated
estimated cardiac output were selected for the 240 minute prior model.
The adjusted odds ratio align with the clinical findings of septic shock. Risk factors, as
determined by the odds ratios, are provided in Table 4.4. As indicated by the adjusted odds
ratios, risk for septic shock increases with a drop in systolic blood pressure, pulse pressure,
SpO2, or arterial pH; additionally, risk for septic shock increases with an increase in heart
rate, respiratory rate, white blood cell count, or cardiac output. All variables selected in
the models are statistically significant as indicated by the p-values. p-values range from <
0.001 to 0.059.
Risk factors for septic shock
Adjusted OR A increase
SpO2  0.22 A5 %
Arterial pH 0.41 A0.1
Systolic Blood Pressure 0.48 A10 mmHg
Pulse Pressure 0.55 A5 mmHg
Heart Rate 1.70 A10 beats per min
Cardiac Output 1.81 A5 units
Respiratory Rate 2.26 A5 breathes per min
White blood cell count 2.41 A10 cells per mm3
Table 4.4: Risk factors for septic shock as derived from the EWS classifiers. Average adjusted odds
ratios per A increase.
4.3.4 Calibration
Additionally, Hosmer-Lemeshow goodness-of-fit testing is provided in Table 4.5 [34]. Ade-
quate goodness-of-fit is indicated by p-value > 0.05. Four of the six models are statistically
"good-fits" while two are not. Analysis of the calibration plots shows the two models that
are not statistically good-fits are skewed by a few outlying points. The plots show that these
models are in fact good-fits. Calibration plots for the models are provided in Appendix A.
EWS Model X2  p-value
30 Min Prior 3.31 0.913
60 Min Prior 3.94 0.862
90 Min Prior 18.32 0.013
120 Min Prior 23.37 0.002
180 Min Prior 7.46 0.483
240 Min Prior 6.68 0.578
Table 4.5: Hosmer-Lemeshow Goodness-of-Fit Testing.
4.3.5 Conclusion
Overall performance amongst the six EWS models is practically indistinguishable. The
models have nearly superimposable ROC curves with overlapping 95% confidence inter-
vals for AUCs. Accuracies, sensitivities, and specificities are functionally equivalent with
slight trade-offs between sensitivity and specificity. Furthermore, there is significant over-
lap in the variables selected as the best indicators; the variables share similar odds ratios.
Additionally, all models show an adequate goodness-of-fit.
Because overall performance was virtually identical in this static evaluation setting, all
EWS models were tested in a forward, causal manner on a random cohort of ICU patients.
Details are provided in Chapter 5.

Chapter 5
Evaluating the Septic Shock Early
Warning System
This chapter details the evaluation of the six septic shock early warning system (EWS)
models discussed in Chapter 4. The models were tested in a forward, causal manner to sim-
ulate performance in an ICU setting. The testing dataset consisted of a random population
of ICU patients sampled from the MIMIC II database. Section 5.1 describes the forward,
causal application of the EWS models to the patient test set; evaluation metrics and gold
standard criteria used to judge performance are provided in Section 5.2. A breakdown of
baseline patient characteristics for the test set is provided in Section 5.3. Lastly, overall
performance of the EWS models is presented in Section 5.4.
5.1 Evaluation Overview
5.1.1 Overall Process
The six EWS models discussed in Chapter 4 were tested in a forward, causal manner to
simulate performance in an ICU setting. A schematic of the overall evaluation process is
provided in Figure 5-1.
Initially, 500 patient records were selected at random from the MIMIC II database
(exclusion criterion age < 18 years). Patient records were passed through the data filter
discussed in Section 3.2.1; patients with insufficient data were eliminated from further
analysis. Of the subset with sufficient data, time intervals during which the patient exhibited
SIRS were determined. The EWS models were applied to patient data within the SIRS
interval, producing a [0, 1] output for each time point. Finally, various summing algorithms
were tested to perform further manipulations on the classifier outputs before the decision
to issue a warning was made. Details on the summing algorithms are provided below.
Figure 5-1: Schematic of the overall EWS evaluation process.
5.1.2 Summing Algorithms
Five different summing algorithms were implemented to perform further manipulation on
the EWS output before deciding to issue a warning. The summing algorithms utilize the
time variant properties of the data by combining consecutive outputs. It was thought that
combining consecutive outputs would confer the following two benefits: (1) mitigate the ef-
fects of single misclassifications, and (2) capture the time devolution towards hemodynamic
instability.
The algorithms took as input a range of 1 to 5 consecutive outputs from the EWS model.
In the trivial case of 1 output, the algorithm returned the output value without modification.
Otherwise, the outputs were combined in the one of the five following manners1:
1. Unweighted sum
n
EWSout xi (5.1)
i=l
in: number of consectutive outputs to combine
i: index of previous output, where i=1 is the current output, i=2 previous output, i=3 2nd previous,
etc.
2. Exponentially weighted sum
n
EWSout = E(xi)i (5.2)
i=l
3. Linearly weighted sum E n - (i - 1)
EWSout = n i .x (5.3)
i=1
4. Multiple consecutive values and unweighted addition
n
EWSout = E xi-1 xi (5.4)
i=2
5. Multiple consecutive values and linearly weighted addition
n n- (i- 1)
EWSout = xi-1 xi -+ xi-1 (5.5)
i=2
The time associated with the new combined output is the time of the most recent output
from the EWS model. For example, if the outputs from minutes 0, 60, 120, and 180 are
combined, the associated time for the combined output is the 180 th minute.
Thus, a total of 21 classifiers were generated for each EWS model-the single unmodified
EWS output, and 4 additional classifiers for each summing algorithm (combining 2 to 5
consecutive outputs).
5.2 Evaluation Metrics
5.2.1 Defining a Gold Standard
Evaluating the performance of the EWS models requires a gold standard by which to judge
the output of the classifiers. In other words, when should the EWS issue an alarm?
The first choice is obvious: an alarm should be issued before an episode of hypotension
despite fluid resuscitation (HDFR). The second choice takes into account therapeutic in-
terventions received by the ICU patient. The start or increase in vasopressors or inotropic
agents typically signifies a state of hemodynamic decompensation; thus, the EWS should
issue an alarm before the start or significant increase in vasopressors or inotropic agents.
The following two choices were made to implement the criteria described above. An
early warning alarm should be issued up to 18 hours prior to:
1. The onset of hypotension despite fluid resuscitation
2. The start or at least 20% increase in vasopressors or inotropic agents.
The onset of HDFR was determined using the septic shock onset detector (SSOD) detailed
in Section 3.2.1. The start or increase in vasopressors/inotropic agents was determined
using medication information. The occurence of either of these events will be referred to as
a gold-standard episode.
5.2.2 Positive & Negative Predictive Value
Positive and negative predictive values (PPV/NPV) measure the proportion of patients
with a positive or negative test result who are correctly diagnosed. In this setting, the PPV
is the probability that a patient will experience a gold-standard episode given that an early
warning was issued. Conversely, the NPV is the probability a patient will not experience a
gold-standard episode if no warning is issued.
Definitions for true positive, false positive, true negative, and false negative alarms are
depicted in Figure 5-2.
18 hours 18 hours
(a) True positive. Onset of a gold- (b) False positive. No gold-standard
standard episode in the 18 hour pe- episode in the 18 hour period after
riod after the early warning. the early warning.
18 hours 18 hours
(c) False negative. Onset of a gold- (d) 'True negative. No gold-standard
standard episode in the 18 hour pe- episode in the 18 hour period after
riod after no early warning. no early warning.
Figure 5-2: Definitions of true positive, false positive, true negative, and false negative alarms used
in calculating positive and negative predictive value (and specificity).
PPV and NPV are defined as:
True Positives
PPV =
True Positives + False Positives
True NegativesNPV =
True Negatives + False Negatives
Both measurements are dependent on the prevalence of the disorder or disease being
classified. Because the test set was generated through a random sampling of ICU patients,
the prevalence of gold-standard episodes in the set should mimic that of a real ICU setting.
Consequently, PPV and NPV values calculated in testing should be applicable if the EWS
models are used in a real-life scenario.
It is important to note that the measured NPV is inherently skewed by the gold-standard
definition of positive data points. A data-point is defined positive if a gold-standard episode
occurs anytime in the following 18 hours. Thus, a high NPV would require issuance of early
warnings for the majority of the prior 18 hours. Consequently, specificity is likely to be a
better measure of the models ability to correctly classify negative gold-standard data points.
5.2.3 Sensitivity & Specificity
Specificity
Specificity is a statistical measure of the proportion of true negatives correctly identified
by the classification test. In this setting, the specificity is the proportion of gold-standard
negative data points the classifier correctly identifies as negatives. Specificity is defined as:
Sensitivity True NegativesSensitivity = True Negatives + False Positives
Definitions for true negative and false positive alarms used to calculate specificity are
depicted in Figure 5-2.
Sensitivity
Sensitivity is a statistical measure independent of the prevalence of the disorder or disease
being classified. Sensitivity is the proportion of all positive cases in a population that are
actually classified as positive. Sensitivity is defined as:
True Positives
True Positives + False Negatives
However, calculating sensitivity using the definitions provided in Figure 5-2 would result
in a skewed measure of the index (as with NPV). For example, in order to achieve a high
sensitivity a significant majority of alarms prior to the 18 hour period of a HDFR episode
would have to be positive. Rather, it makes more sense to calculate sensitivity as the
proportion of gold-standard episodes which are detected prior to their onset. Thus, the
model would not be penalized for detecting the episode only 6 hours prior rather than the
full 18 hours. Figure 5-3 shows the definitions used to calculate sensitivity.
- - - r - - - I
18 hours 18 hours
(a) True positive. Early warning is- (b) False negative. No early warning
sued in the 18 hour period prior to issued in the 18 hour period prior to
the onset of a gold-standard episode. the onset of a gold-standard episode.
Figure 5-3: Definitions of true positive, and false negative alarms used in calculating sensitivity.
5.3 Test Patient Characteristics
A random sample of 500 ICU patients were selected from the MIMIC II dataset with
an exclusion criterion of age < 18 years. Patient records were then passed through a
primitive data filter (Section 3.2.1); patients with insufficient data were excluded from
further analysis. Table 5.1 highlights various patient characteristics of the subset with
sufficient data for analysis.
Out of the 500 random patients, 210 patients had sufficient data for further analysis.
165 of the 210 exhibited SIRS while in the unit. Of that subset, 26 patients went on to
experience HDFR. The 210 patient dataset covers 41,475 patient-hours (average stay of
approximately 8 days)-breakdown of patient-hours between patient types is provided in
Table 5.1.
Age, yrs
Male sex, %
Total patients, n
Patient hours, hr
Med Start/Increase, n
HDFR Episodes, n
Physiological Values
SIRS criteria
Systolic BP, mmHg
HR, beats per min
Temperature, 'C
RR, breathes per min
WBC, cells/mm3
Miscellaneous
Pulse Pressure, mmHg
Arterial pH
SPo 2, %
Total fluids, mL
0-6 hrs
6-24 hrs
0-24 hrs
No SIRS
63 ± 15 (63)
49 (22)
45
5023
N/A
N/A
133 ± 26 (132)
81 ± 15 (80)
36.5 + 0.9 (36.6)
15 ± 4 (14)
10.9 ± 3.8 (10.8)
70 ± 23 (69)
7.38 ± 0.08 (7.40)
98 ± 2.8 (100)
2760 ± 2994 (1375)
2319 ± 1159 (2073)
5023 ± 3284 (4002)
SIRS only
64 ± 15 (66)
55 (77)
139
26429
142
126 ± 27 (122)
89 ± 18 (89)
36.6 ± 1.1 (36.6)
18 ± 7 (17)
13.2 ± 7.7 (12.6)
63 ± 20 (62)
7.35 ± 0.08 (7.36)
97 ± 5.8 (99)
2428 ± 3172 (1065)
2209 ± 1940 (1875)
4582 ± 4245 (3500)
HDFR
60 ± 18 (63)
73 (19)
26
10026
111 ± 25 (110)
100 ± 18 (101)
36.4 ± 1.2 (36.5)
18 ± 7 (17)
10.6 ± 7.5 (11.7)
51 ± 17 (48)
7.33 ± 0.10 (7.35)
97 ± 4.3 (99)
3389
3488
6784
± 4273
± 2705
± 6480
(1850)
(2535)
(4669)
Vasopressors/Inotropes
0-6 hrs, %
6-24 hrs, %
0-24 hrs, %
33 (15)
5 (2)
38 (17)
33 (47)
7 (9)
40 (56)
54 (14)
4(1)
58 (15)
Table 5.1: Baseline patient characteristics for the random patient cohort.
SIRS, systemic inflammatory response syndrome; HDFR, hypotension despite fluid resuscitation; BP, blood pres-
sure; HR, heart rate; RR, respiratory rate; WBC, white blood cell count; Spo 2 , pulse oximetry oxygen saturation.
Vasopressor/Inotropes presented as % of patients started during time interval.
Continuous values presented as mean ± std (median); dichotomous values presented as % (n).
Table 5.1 also provides the breakdown of the gold standard episodes present in the pa-
tient population. There are a total of 229 starts or 20% increases in vasopressors/inotropes
within the patient population. 142 of the events occurred in patients who only exhibit SIRS
while 87 occurred in patients who experience HDFR. Additionally, 42 episodes of HDFR
occurred amongst 26 patients.
5.4 Results
21 classifiers for each EWS model were tested-the single unmodified EWS output, and 4
additional classifiers for each summing algorithm (combining 2 to 5 consecutive outputs).
Thus, a total of 126 different classifiers were tested. It is impractical and moreover irrelevant
to provide detailed results for each classifier. Sensitivity versus PPV plots are provided for
all classifiers in Appendix B. However, detailed results are only provided for what was
deemed the best model.
The 36,455 patient-hours of data from the random patient cohort generated approx-
imately 16,000 data points for classification. The EWS models were applied to the data
points as previously described. Sensitivity, specificity, PPV, and NPV were calculated using
the definitions provided in Section 5.2.2 and 5.2.3.
5.4.1 Sensitivity versus Positive Predictive Value
Sensitivity and specificity were determined using different definitions for the reasons men-
tioned previously; as a result, it was impossible to create meaningful ROC curves for the
classifiers. However, since PPV was calculated, it was possible to generate plots which cap-
ture the trade-off between the ability to detect gold-standard episodes and false alarm rates
(sensitivity versus PPV). Figure 5-4 shows a sample sensitivity versus PPV plots for the 120
minute prior EWS model using Summing Algorithm 1. Figure 5-4(a) is a plot of sensitivity
for all gold-standard episodes versus PPV whereas Figure 5-4(b) is a plot of sensitivity for
HDFR episodes versus PPV.
All 126 EWS classifiers provided early warnings for HDFR episodes with a higher sensi-
tivity than for the start/increase in vasopressors/inotropes. The plots provided in Appendix
B are for sensitivity of HDFR episodes versus PPV. The justification for using sensitivity
for only HDFR episodes and PPV for all gold-standard episodes is as follows: the models
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Figure 5-4: Plots of sensitivity versus positive predictive value (PPV) for the 120 minute prior model
using Summing Algorithm 1. The legend denotes the number of consecutive outputs combined for
each curve. The first number denotes the Summing Algorithm used; the subscript indicates the
number of consecutive outputs combined. For example, 23 refers to Summing Algorithm 2 combining
3 consecutive outputs.
were trained to detect episodes of HDFR and not changes in medication status. However,
if an early warning occurs before a start or increase in vasopressors/inotropes, this signifies
the patient was devolving into a state of hemodynamic instability and medications were
required to prevent further decompensation. Thus, the early warning signal was in fact a
true alarm but therapeutic intervention potentially prevented progression to HDFR.
Analysis of the sensitivity versus PPV plots indicates the best classifier to be the 120
minute prior model using no summing algorithm. The classification threshold with the
highest clinical utility was identified as the point with a sensitivity of 85% and PPV of 70%
(corresponding to a threshold of 0.87).
5.4.2 Detailed Results
The following sections provide detailed results for the 120 minute prior EWS model using
no summing algorithm; this model was considered the best fit out of the 126 classifiers.
Distribution of Outputs
Figure 5-5 shows the distribution of classifier output values for the 120 minute prior model
using no summing algorithm; the top plot is a histogram of classifier outputs for data points
12
13
14
15
with gold-standard codings 2 of 0, vice versa for the bottom plot.
(a) Histogram of classifier output values for data points with a gold-standard coding of 0.
(b) Histogram of classifier output values for data points with a gold-standard coding of 1.
Figure 5-5: Distribution of classifier output values for the 120 minute prior model using no summing
algorithm.
The model is highly specific in classifying the occurrence of no gold-standard episodes as
indicated by the high concentration of low output values in the Figure 5-5(a). Conversely, it
appears that many positive gold-standard data points go undetected as indicated in Figure
5-5(b). However, it is important to reiterate that a data point is defined as gold-standard
positive if any gold-standard episode occurs in the following 18 hours. If the episode was
detected only 6 hours previous of occurrence, 12 of the remaining 18 hours of data would
be classified as false negatives. Thus, the high occurrence of low output values for positive
gold-standard data points is irrelevant since it is only the maximum output value in the 18
hours prior that matters.
Figure 5-6 provides the maximum classifier output value in the 18 hours prior to gold-
standard episodes for the 120 minute prior model using no summing algorithm. The top
figure is a histogram of the maximum outputs 18 hours prior to the start/increase in vaso-
2Data points with no gold-standard episodes in the following 18 hours are coded as a 0. Data points with
the onset of gold-standard episodes in the following 18 hours are coded as 1.
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pressors/inotropes; the bottom is for episodes of HDFR. The model is highly discriminate
in its ability to detect episodes of HDFR; the model does not perform as well in regard to
changes in medication status.
(a) Histogram of maximum classifier values 18 hours prior to the start/increase of vasopres-
sors/inotropes.
S ,-,I
(b) Histogram of maximum classifier values 18 hours prior to HDFR episodes.
Figure 5-6: Distribution of maximum classifier values 18 hours prior to gold-standard episodes for
the 120 minute prior model using no summing algorithm.
Overall Performance
Table 5.2 provides performance indices for the model when run at a threshold of 0.87. This
threshold was considered to confer the greatest clinical utility by achieving high sensitivity
while still performing with an acceptable false positive rate.
The model performed at a sensitivity and specificity of 0.85 and 0.96, respectively. This
resulted in a PPV and NPV of 0.70 and 0.73, respectively. The model detected 29 out
of 34 episodes of HDFR with a mean early warning time of 582 minutes (median 600).
Additionally, the model detected 124 out of 229 start/increases in vasopressors/inotropes
with a mean early warning time of 507 minutes (median 528).
Performance Indices GS Episodes Detected Mean Early Warning Time
Sens Spec PPV NPV HDFR Med Change HDFR Med Change
0.85 0.96 0.70 0.73 29 (34) 124 (229) 582 + 355 (600) 507 ± 326 (528)
Table 5.2: Overall performance measures for the 120 minute prior model using no summing algorithm
at a classifier threshold of 0.87.
GS episodes detected presented as number detected (total number). Mean early warning time presented as mean
- std (median).
GS, gold-standard; PPV, positive predictive value; NPV, negative predictive value; HDFR, hypotension despite
fluid resuscitation; Med Change, start or 20% increase in vasopressors/inotropes.
Sample Patient Run
Figure 5-7 shows a sample patient run of the EWS model. Five clinical values are provided
to track the state of the patient: (1) systolic blood pressure, (2) heart rate, (3) white
blood cell count, (4) temperature, and (5) respiratory rate. The bottom plot shows the
output of the EWS model. Red points indicate the issuance of an early warning (output >
threshold). The red vertical line denotes an episode of HDFR; the blue vertical lines denote
a start/increase in vasopressors/inotropes. The frequency of early warnings increases in the
time interval prior to the patient experience gold-standard episodes.
Additional sample patient runs are provided in Appendix C.
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Figure 5-7: A sample patient run of the EWS model. Five clinical values are provided to track
the state of the patient: (1) systolic blood pressure, (2) heart rate, (3) white blood cell count, (4)
temperature, and (5) respiratory rate. The bottom plot shows the output of the EWS model. Red
points indicate the issuance of an early warning (output > threshold). The red vertical line denotes
an episode of HDFR; the blue vertical lines denote a start/increase in vasopressors/inotropes. The
frequency of early warnings increases in the time interval prior to the patient experiencing a gold-
standard episode.
t

Chapter 6
Discussion & Conclusion
6.1 Discussion
This section outlines the strengths and weaknesses of the early warning system (EWS) in
the context of: (1) overall performance in a simulated setting, and (2) clinical applicability
in a real-life setting. The discussion is focused on the overall EWS concept; thus, the
concentration is not on the particular details of the individual classifiers, but rather the
system as a whole.
6.1.1 Overall Performance
The septic shock EWS performed with high sensitivity and specificity in both static (Chap-
ter 4) and dynamic (Chapter 5) evaluation. In both evaluation settings, the model achieved
sensitivities in the mid-to-upper 80's and specificities in the upper 80's to mid 90's. Because
the indices are independent of prevalence, it is unremarkable the EWS performed similarly
in both testing scenarios.
When evaluated in a forward, causal manner to simulate an ICU setting, the model
provided early warnings for the majority of episodes of hypotension despite fluid resuscita-
tion (HDFR); the mean early warning time was approximately 10 hours. As stated above,
the model was able to provide early warnings with high specificity. Despite the high level
of specificity, the model conferred a substantially lower positive predictive value (approxi-
mately 70%). Then the question is: in the face of both high sensitivity and specificity, why
does the EWS perform at a mediocre level of PPV?
Positive Predictive Value
PPV is related to the sensitivity and specificity of the model through the prevalence of the
disorder in the population. The relationship is provided below:
PPV = Sensitivity -Prevalence
Sensitivity -Prevalence + (1 - Specificity) - (1 - Prevalence)
PPV is positively related to sensitivity, specificity, and prevalence. With respect to the
EWS, prevalence refers to the proportion of data points in the test set which are defined
as gold-standard positive (as defined in Section 5.2.1). Figure 6-1 plots the relationship
between PPV and prevalence for the EWS1 assuming sensitivity and specificity values of
0.85 and 0.96, respectively (Section 5.4.2).
CL0.a,
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Figure 6-1: Positive predictive value (PPV) as a function of prevalence for the EWS.
As shown in Figure 6-1, the mediocre PPV of the EWS is a consequence of the low
prevalence of positive episodes in the test population. This finding is further corrobo-
rated through analysis of the test patient population. Of the total 36,455 patient-hours
of data classified by the EWS, there were only 271 gold-standard episodes--or roughly 1
gold-standard episode per 130 patient-hours. Thus, achieving a high PPV is inherently com-
1Sensitivity and specificity were determined using different definitions for true positive, false positive, true
negative, and false negative alarms. As a result, the relationship presented is not completely accurate-but
rather a first-order approximation.
plicated by the low prevalence of the disorder. Nonetheless, thoughts on how to improve
PPV are provided in Section 6.1.2.
HDFR Non-Specific to Septic Shock
The EWS displayed a remarkable ability to provide prior warnings for the hallmark of septic
shock: hypotension despite fluid resuscitation. Out of the 34 occurrences of HDFR found
in the test patient population, the model detected all but 5 episodes. However, only 2 out
of the 26 patients who experienced HDFR had ICD-9 codings for septic shock.
The non-specific relationship between HDFR and septic shock does not limit the clinical
utility of the EWS. For patients with previously documented or suspected infection, an early
warning may forecast the clinical progression on the sepsis spectrum. For patients without
previous sepsis suspicion, an early warning may flag an infectious etiology overlooked by
clinicians. Lastly, for patients with a known etiology that may also result in HDFR (i.e.
burn victims), an early warning may signify the need for an increase or change in therapeutic
intervention.
As a result of its non-specificity, labeling the EWS as an exclusive septic shock predictor
is both inaccurate and incomplete. The EWS, when coupled with clinical common sense,
has the ability to confer greater clinical utility than an exclusive septic shock detector. One
potential area for future work may focus on the ability to further stratify episodes of HDFR
into septic and non-septic etiologies.
6.1.2 Clinical Applicability
The utility of the EWS in a clinical setting is an issue of utmost importance. Both static
and dynamic evaluation of the EWS has demonstrated the model's ability to provide early
warnings for HDFR. However, clinical applicability of the EWS is dependent upon a variety
of factors aside from sensitive detection.
False Alarms
When tested in a simulated ICU setting, the EWS performed with a PPV of 70%-
approximately one false alarm out of every four alarms. No minimum benchmark for PPV
has been set, but it is unlikely a 30% false alarm rate would be acceptable in a clinical
setting. As described above, increasing the model's PPV is inherently complicated by the
low prevalence of the disorder in the patient population. Nonetheless, a potential solution
is outlined below.
The EWS classifier performs at a high level of sensitivity and specificity; therefore, it
is unlikely to be able to improve PPV through increases in either index. Then the only
portion of the EWS left to modify is the post-classification processing applied to the EWS
outputs. Ultimately, I believe the key to increasing PPV lies in finding the correct set of
post-classification manipulations.
The use of various summing algorithms (Section 5.1.2) to combine consecutive EWS
outputs was an attempt to increase PPV through post-classification processing. Unfortu-
nately, the summing algorithms conferred no added benefit in PPV as the best classifier
simply used the unmodified 120 minute prior EWS model. The shortcoming of the summing
algorithms, I believe, was processing only consecutive outputs and not analyzing temporal
patterns.
Analysis of EWS output plots indicates one key difference between true positive and
false positive early warnings may lie in the frequency of positive classifier outputs. Multiple
consecutively positive outputs are common in the surrounding regions of both true and false
positive early warnings. However, the occurrence of such patterns appears more frequently
in the regions surrounding true positive early warnings. Furthermore, in many cases the
frequency of positive classifier outputs increases closer to the onset of the gold-standard
episode (as shown in Figure 5-7).
Thus, combining the summing algorithms with pattern frequency analysis is likely to
result in an increase in PPV. A likely consequence is a reduction in early warning time-an
unfortunate necessity to ensure clinical applicability.
Therapeutic Interventions
A wide variety of pathologies may send a patient to the ICU, but one characteristic is
evident amongst them all-the resultant physiologic instability. As a result, the ICU patient
is barraged with a multitude of therapeutic interventions in hopes to stabilize the patient.
Consequently, any algorithm designed to run in a dynamic ICU setting must either: (1)
explicitly account for therapeutic interventions, or (2) perform accurately irrespective of
administered treatments.
A strong argument can be made that the EWS conforms to the latter. In the simulated
ICU evaluation, a variety of pathologies accounted for the HDFR seen in patients. Almost
all HDFR patients received vasopressors and/or inotropic agents in addition to interventions
particular to their disease. Nonetheless, the EWS was able to detect the majority of HDFR
episodes-thus implying functionality irrespective of therapeutic interventions.
6.2 Conclusion
This thesis has demonstrated the ability to provide early warnings for the onset of septic
shock using commonly measured clinical variables. The early warning system (EWS), a
multivariate logistic regression model, provided prior warnings for the onset of hypotension
despite fluid resuscitation (HDFR) with both high sensitivity and specificity. Furthermore,
the warnings were issued in a time frame in which early goal-directed therapy (EGDT)
would likely have therapeutic benefit.
Despite high sensitivity and specificity, the EWS model performed at a substantially
lower positive predictive value (PPV); this mediocre PPV can be attributed to the low
prevalence of HDFR in the test patient population. Additionally, the detection of episodes
of HDFR was non-specific to septic shock. However, when coupled with clinical common
sense, this unforeseen functionality may confer greater clinical utility than an exclusive
septic shock detector.
Two potential areas for future work include: (1) increasing the PPV of the EWS, and
(2) further stratifying early warnings into septic and non-septic etiologies. Both areas focus
on addressing issues critical to the clinical applicability of the EWS.

Appendix A
Calibration Plots for EWS Models
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Figure A-1: Calibration plots for EWS models (deciles). Blue line denotes model's line of best fit.
Red line denotes line of perfect fit.
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Appendix B
Sensitivity versus PPV Plots for
EWS Models
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Figure B-1: Sensitivity versus PPV plots for 30 minute prior model.
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Figure B-2: Sensitivity versus PPV plots for 60 minute prior model.
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Figure B-3: Sensitivity versus PPV plots for 90 minute prior model.
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Figure B-4: Sensitivity versus PPV plots for 120 minute prior model.
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Figure B-5: Sensitivity versus PPV plots for 180 minute prior model.
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Figure B-6: Sensitivity versus PPV plots for 240 minute prior model.
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Appendix C
Early Warning System: Sample
Patient Runs
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Figure C-1: A sample patient run of the EWS model. Five clinical values are provided to track
the state of the patient: (1) systolic blood pressure, (2) heart rate, (3) white blood cell count, (4)
temperature, and (5) respiratory rate. The bottom plot shows the output of the EWS model. Red
points indicate the issuance of an early warning (output > threshold). The red vertical line denotes
an episode of HDFR; the blue vertical lines denote a start/increase in vasopressors/inotropes. A
single warning is issued prior to the episode of HDFR and start of vasopressors/inotropes. No early
warning is provided for the change in medication during hour 98.
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Figure C-2: A sample patient run of the EWS model. Five clinical values are provided to track
the state of the patient: (1) systolic blood pressure, (2) heart rate, (3) white blood cell count, (4)
temperature, and (5) respiratory rate. The bottom plot shows the output of the EWS model. Red
points indicate the issuance of an early warning (output > threshold). The red vertical line denotes
an episode of HDFR; the blue vertical lines denote a start/increase in vasopressors/inotropes. Inter-
mittent warnings are issued prior the first episode of HDFR, after which warnings are continuously
issued-providing warnings for the 2 nd and 3 rd episodes of HDFR along with changes in medication.
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Figure C-3: A sample patient run of the EWS model. Five clinical values are provided to track
the state of the patient: (1) systolic blood pressure, (2) heart rate, (3) white blood cell count, (4)
temperature, and (5) respiratory rate. The bottom plot shows the output of the EWS model. Red
points indicate the issuance of an early warning (output > threshold). The red vertical line denotes
an episode of HDFR; the blue vertical lines denote a start/increase in vasopressors/inotropes.
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Figure C-4: A sample patient run of the EWS model. Five clinical values are provided to track
the state of the patient: (1) systolic blood pressure, (2) heart rate, (3) white blood cell count, (4)
temperature, and (5) respiratory rate. The bottom plot shows the output of the EWS model. Red
points indicate the issuance of an early warning (output > threshold). The red vertical line de-
notes an episode of HDFR; the blue vertical lines denote a start/increase in vasopressors/inotropes.
Early warnings provided the episode of HDFR along with 3 out of the 4 start/increases in vasopres-
sors/inotropes.
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Figure C-5: A sample patient run of the EWS model. Five clinical values are provided to track
the state of the patient: (1) systolic blood pressure, (2) heart rate, (3) white blood cell count, (4)
temperature, and (5) respiratory rate. The bottom plot shows the output of the EWS model. Red
points indicate the issuance of an early warning (output > threshold). The red vertical line denotes
an episode of HDFR; the blue vertical lines denote a start/increase in vasopressors/inotropes. EWS
fails to provide early warnings for the episode of HDFR.
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Appendix D
Patient ID Numbers
Appendix D provides the list of patient ID numbers (PIDs) for patients used to (1) develop
the early warning system (EWS) models (discussed in Chapter 4), and (2) test the EWS
models in a forward, causal manner (discussed in Chapter 5).
Table D.1 provides the PIDs for all patients in the MIMIC II database with an ICD-9
coding for septic shock. The subset of patients who exhibited SIRS while in the unit are
denoted in, , , and red text. Of the subset of who exhibited SIRS, patients who progress
to experience hypotension despite fluid resuscitation are denoted in red text. As discussed
in Chapter 4, the EWS classifiers were trained to differentiate between patients with sepsis
(. ) and those who progress to septic shock (red).
Table D.2 provides the PIDs for the random cohort of patients selected to test the
EWS models in a forward, causal manner. All 500 PIDs are provided in the table; patients
without sufficient data for analysis are denoted in black text. Patients denoted in green
text had sufficient data for analysis but did not exhibit SIRS in the unit. Patients denoted
in -,, red, and blue text exhibited SIRS while in the unit. Of that subset, patients who
experience hypotension despite fluid resuscitation (HDFR) are denoted in red and blue text.
Only two of the patients who experienced HDFR had ICD-9 codings for septic shock-those
patients are denoted in blue.
b60023
b60035
b60150
b60189
b60400
b60462
b60702
b60767
b60901
b60953
b61086
b61121
b61184
b61197
b61250
b61290
b61312
b61368
b61397
b61401
b61418
b61426
b61446
b61645
b61860
b61928
b61995
b62343
b62364
b62397
b62513
b62553
b62890
b62985
b63045
b63183
b63338
b63400
b63486
b63539
b63542
b63642
b63662
b63688
b63885
b63917
Table D.1: PIDs for all patients in the MIMIC II database with an ICD-9 coding for septic shock.
The subset of patients who exhibited SIRS while in the unit are denoted in and red text.
Of the subset of who exhibited SIRS, patients who progress to experience hypotension despite fluid
resuscitation are denoted in red text. As discussed in Chapter 4, the EWS classifiers were trained to
differentiate between the patients with sepsis ( ) and those who progress to septic shock (red).
b64058
b64062
b64148
b64150
b64167
b64279
b64504
b64507
b64663
b64805
b64819
b64934
b64998
b65043
b65079
b65126
b65176
b65407
b65495
b65512
b65662
b65758
b65797
b65839
b65895
b65902
b65943
b66085
b66086
b66101
b66112
b66497
b66512
b66558
b66760
b66779
b66796
b66807
b66967
b67072
b67174
b67216
b67259
b67320
b67389
b67488
b67514
b67520
b67641
b67664
b67707
b67727
b67846
b67867
b68058
b68258
b68333
b68600
b68830
b68852
b68876
b68914
b68941
b69238
b69627
b69688
b69820
b69891
b70071
b70225
b70243
b70333
b70409
b70496
b70500
b70705
b70750
b70765
b70924
b70944
b70983
b71136
b71170
b71266
b71330
b71437
b71737
b71834
b71845
b72022
b72037
b72044
b72150
b72223
b72233
b72255
b72284
b72461
b72472
b72492
b72623
b72702
b72740
b72817
b72934
b73004
b73139
b73155
b73226
b73332
b73578
b73661
b73855
b73907
b73987
b73995
b74030
b74169
b74452
b74560
b74609
b74617
b74637
b74642
b74686
b74756
b74936
b74937
b75109
b75122
b75143
b75168
b75177
b75276
b75321
b75335
b75485
b75536
b75556
b75605
b75643
b75647
b75664
b75956
b75991
b76089
b76181
b76257
b76322
b76369
b76377
b76505
b76575
b76599
b76756
b76770
b76790
b76827
b76937
b77014
b77070
b77417
b77432
b64353
b64625
b64662
b)65275
b66039
b66389
b66863
b67064
b67445
b67486
b67545
b)67775
b67928
b68120
b68256
b68587
b68617
b69374
b69613
b69707
b69869
b70096
b70272
b70304
b70383
b70523
b71203
b60134 b71587
b60159 b71759
b60320 b72120
b60361 b72374
b60885 b72665
b60999 b74843
b61046 b74956
b61057 b75016
b61345 b75574
b61434 b75707
b61642 b75929
b61952 b76350
b62730 b76351
b63318 b76366
b63668 b76558
b63671 b76614
b63812 b77206
b63815 b77292
b63946
·,
~
b60052
b60119
b60146
b60185
b60281
b60333
b60420
b60582
b60616
b60637
b60644
b60682
b60766
b60832
b61033
b61066
b61133
b61158
b61276
b61343
b61463
b61468
b61588
b61612
b61688
b61771
b61846
b62035
b62085
b62144
b62234
b62260
b62286
b62497
b62611
b62643
b62747
b62771
b62832
b62847
b62874
b62886
b62995
b63008
b63138
b63205
b63262
b63367
b63419
b63452
b63496
b63522
b63599
b63672
b63708
b63756
b63796
b63836
b64051
b64199
b64437
b64692
b64766
b64882
b65002
b65038
b65046
b65075
b65195
b65203
b65205
b65291
b65323
b65357
b65457
b65495
b65598
b65627
b65638
b65754
b65777
b65832
b65841
b65872
b65885
b65920
b65953
b65997
b66025
b66067
b66335
b66380
b66425
b66446
b66488
b66581
b66582
b66605
b66675
b66698
b66721
b66807
b66881
b66899
b66933
b67036
b67053
b67164
b67295
b67313
b67434
b67461
b67507
b67514
b67535
b67625
b67662
b67701
b67788
b67820
b67856
b67896
b67931
b68049
b68168
b68181
b68220
b68436
b68487
b68574
b68578
b68679
b68705
b68742
b68757
b68812
b68838
b68841
b68896
b68910
b68911
b68914
b68917
b69161
b69255
b69432
b69435
b69446
b69460
b69598
b69651 b72812 b76058
b69714 b72820 b76072
b69760 b72905 b76176
b69867 b72921 b76262
b69868 b72963 b76307
b69890 b72968 b76324
b69913 b73177 b76385
b69914 b73228 b76476
b70071 b73231 b76557
b70225 b73273 b76560
b70256 b73285 b76566
b70258 b73455 b76576
b70319 b73472 b76593
b70332 b73494 b76735
b70409 b73508 b76758
b70477 b73556 b76778
b70484 b73579 b76783
b70504 b73598 b76789
b70600 b73696 b76806
b70830 b73752 b76826
b70906 b73804 b76855
b70992 b73844 b76901
b71072 b73926 b76908
b71117 b74006 b76928
b71156 b74020 b76967
b71273 b74029 b76982
b71295 b74208 b77008
b71334 b74224 b77045
b71507 b74492 b77070
b71513 b74617 b77097
b71522 b74649 b77124
b71637 b74911 b77132
b71650 b74925 b77191
b71684 b74990 b77284
b71742 b75006 b77377
b71783 b75103 b77387
b71785 b75143 b77466
b71847 b75308 b77487
b71875 b75315 b60369
b72204 b75458 b60917
b72275 b75543 b61249
b72366 b75547 b62045
b72442 b75564 b62086
b72516 b75566 b62158
b72636 b75591 b62728
b72661 b75602 b63494
b72732 b75692 b63821
b72740 b75726 b64031
b72760 b75836 b64078
b72778 b76057 b64188
Table D.2: PIDs for the random cohort of patients selected to test the EWS models in a forward,
causal manner. All 500 PIDs are provided in the table; patients without sufficient data for analysis
are denoted in black text. Patients denoted in green text had sufficient data for analysis but did not
exhibit SIRS in the unit. Patients denoted in I:,, red, and blue text exhibited SIRS while in the
unit. Of that subset, patients who experience hypotension despite fluid resuscitation (HDFR) are
denoted in red and blue text. Only two of the patients who experienced HDFR had ICD-9 codings
for septic shock-those patients are denoted in blue.
b64410
b64767
b65765
b66127
b66623
b66760
b67611
b67743
1)68338
b68990
b69014
b69323
b70794
b71183
b71230
b71585
b71892
b71938
b72186
b72583
b72946
b73699
b74514
b75303
b75333
b75345
b75640
b76037
b76050
b76149
b76626
b77062
b77268
b60876
b61375
b61428
b61952
b63594
b64095
b64381
b64855
b65254
b66853
b68712
b69442
b70118
b70251
b70981
b73243
b73362
b73865
b74389
b74633
b75921
b75933
b75935
b76261
b76495
b77054
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